文献速递腹部US

超声造影定量评估肝实质局灶性脂肪变异:挑战与邻近肝实质均匀强化传统定性范式的对比

Contrast-Enhanced Ultrasound Quantification Assessment of Focal Fatty Variations in Liver Parenchyma: Challenging the Traditional Qualitative Paradigm of Uniform Enhancement With Adjacent Parenchyma.
PubMed 文献 · J Ultrasound Med · 2020-09-20

回顾性观察研究纳入42例(26例局灶性脂肪豁免、16例局灶性脂肪浸润),用超声造影定量参数比较病灶与邻近肝实质。局灶性脂肪豁免的峰值增强、灌注曲线下面积、灌注速率和灌注指数显著低于邻近肝实质,而局灶性脂肪浸润无显著差异;仅灌注速率在局灶性脂肪豁免中显著低于局灶性脂肪浸润。

要点

  • 局灶性脂肪豁免在动脉期可表现为低增强,静脉期和延迟期均等增强。
  • 局灶性脂肪豁免的峰值增强、灌注曲线下面积、灌注速率和灌注指数显著低于邻近肝实质。
  • 局灶性脂肪浸润的定量参数与邻近肝实质无显著差异,仅灌注速率在脂肪豁免中显著低于脂肪浸润。

关键影像表现/征象

  • 主观评估显示,动脉期27%的局灶性脂肪豁免和25%的局灶性脂肪浸润呈低增强,73%的局灶性脂肪豁免和75%的局灶性脂肪浸润呈等增强。
  • 静脉期和延迟期所有病灶均呈等增强。

诊断标准与关键数值

  • 局灶性脂肪豁免的峰值增强P=0.001、灌注曲线下面积P<0.01、灌注速率P=0.023和灌注指数P=0.001显著低于邻近肝实质,平均通过时间无显著差异。
  • 局灶性脂肪浸润亚组中,各定量参数与邻近肝实质无显著差异。
  • 相对参数比较中,仅灌注速率在局灶性脂肪豁免中显著低于局灶性脂肪浸润(P=0.049)。

临床应用与阅片要点

  • 阅片时应注意局灶性脂肪豁免在动脉期可呈低增强,静脉期和延迟期呈等增强,定量参数有助于与局灶性脂肪浸润鉴别。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: The purpose of this study was to quantify contrast-enhanced ultrasound enhancement of focal fatty sparing (FFS) and focal fatty infiltration (FFI) and compare it with adjacent liver parenchyma.

METHODS: This was a retrospective observational study yielding 42 cases in the last 4 years. Inclusion criteria were a focal liver lesion, adequate video availability, and an established diagnosis of FFS or FFI based on clinical or imaging follow-up or a second modality. Contrast-enhanced ultrasound examinations were performed with a standard low-mechanical index technique. Commercially available software calculated quantitative parameters for a focal liver lesion and a reference area of liver parenchyma, producing relative indices.

RESULTS: In total, 42 patients were analyzed (19 male) with a median age of 18 (interquartile range, 42) years and a median lesion diameter of 30 (interquartile range, 16) mm. The cohort included 26 with FFS and 16 with FFI. Subjectively assessed, 27% of FFS and 25% of FFI were hypoenhancing in the arterial phase, and 73% of FFS and 75% of FFI were isoenhancing. In the venous and delayed phases, all lesions were isoenhancing. The peak enhancement (P = .001), wash-in area under the curve (P < .01), wash-in rate (P = .023), and wash-in perfusion index (P = .001) were significantly lower in FFS compared with adjacent parenchyma but not the mean transit time. In the FFI subgroup, no significant difference was detected. Comparing relative parameters, only the wash-in rate was significantly (P = .049) lower in FFS than FFI. The mean follow-up was 2.8 years.

CONCLUSIONS: Focal fatty sparing shows significantly lower and slower enhancement than the liver parenchyma, whereas FFI enhances identically. Focal fatty sparing had a significantly slower enhancement than FFI.

来源:J Ultrasound Med,查看原文。版权归原作者所有。

引用

  1. Rafailidis V, Fang C, Leenknegt B, et al. Contrast-Enhanced Ultrasound Quantification Assessment of Focal Fatty Variations in Liver Parenchyma: Challenging the Traditional Qualitative Paradigm of Uniform Enhancement With Adjacent Parenchyma. J Ultrasound Med. 2020. PMID: 32951283. doi:10.1002/jum.15494

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。